Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Pfaar

Showing results (271-280 of 308) with videos related to

Pageof 31
Sort By:
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|May 5, 2020
Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 25, 2022
Cutoff Values of MASK-air Patient-Reported Outcome MeasuresBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Translational Allergy|May 28, 2024
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air studyBernardo Sousa-Pinto, Gilles Louis, Rafael J Vieira, et al.
Pulmonology|July 28, 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthmaBernardo Sousa-Pinto, Florence Schleich, Gilles Louis, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Pageof 31

Showing results (271-280 of 308) with videos related to

Sort By:
Pageof 31
Allergologie Select|June 23, 2020
Allergen immunotherapy in the current COVID-19 pandemic: A position paper of AeDA, ARIA, EAACI, DGAKI and GPA: Position paper of the German ARIA Group<sup>A</sup> in cooperation with the Austrian ARIA Group<sup>B</sup>, the Swiss ARIA Group<sup>C</sup>, German Society for Applied Allergology (AEDA)<sup>D</sup>, German Society for Allergology and Clinical Immunology (DGAKI)<sup>E</sup>, Society for Pediatric Allergology (GPA)<sup>F</sup> in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC<sup>G</sup> and the European Academy of Allergy and Clinical Immunology (EAACI)<sup>H</sup>Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Allergo Journal : Interdisziplinare Zeitschrift Fur Allergologie Und Umweltmedizin : Organ Der Deutschen Gesellschaft Fur Allergie- Und Immunitatsforschung|May 5, 2020
Ludger Klimek, Oliver Pfaar, Margitta Worm, et al.
Clinical and Translational Allergy|September 27, 2021
Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air®Bernardo Sousa-Pinto, Patrik Eklund, Oliver Pfaar, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 25, 2022
Cutoff Values of MASK-air Patient-Reported Outcome MeasuresBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Translational Allergy|May 28, 2024
Relevance of individual bronchial symptoms for asthma diagnosis and control in patients with rhinitis: A MASK-air studyBernardo Sousa-Pinto, Gilles Louis, Rafael J Vieira, et al.
Pulmonology|July 28, 2025
Daily digital biomarkers in the follow-up and clustering of patients with asthmaBernardo Sousa-Pinto, Florence Schleich, Gilles Louis, et al.
Allergy|December 21, 2021
Development and validation of combined symptom-medication scores for allergic rhinitisBernardo Sousa-Pinto, Luís Filipe Azevedo, Marek Jutel, et al.
Allergy|March 8, 2022
Behavioural patterns in allergic rhinitis medication in Europe: A study using MASK-air<sup>®</sup> real-world dataBernardo Sousa-Pinto, Ana Sá-Sousa, Rafael José Vieira, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|January 1, 2019
Adherence to treatment in allergic rhinitis using mobile technology. The MASK StudyEnrica Menditto, Elisio Costa, Luis Midão, et al.
Allergy|November 3, 2022
Consistent trajectories of rhinitis control and treatment in 16,177 weeks: The MASK-air® longitudinal studyBernardo Sousa-Pinto, Holger J Schünemann, Ana Sá-Sousa, et al.
Pageof 31